GSGianfranco De Stefano

Gianfranco De Stefano

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gianfranco De Stefano has a total of 79 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Postcentral cortical thickness reduction in trigeminal neuralgia: a whole-brain surface-based morphometry MRI study

    by Gianfranco De Stefano, Daniel Litewczuk, Davide Chiffi, Eleonora Galosi, Giuseppe Di Pietro, Enrico Evangelisti, Pietro Falco, Caterina Maria Leone, Marco Fiorelli, Francesca Caramia, et al.

    Introduction: Trigeminal neuralgia (TN) is a neuropathic pain disorder characterized by paroxysmal unilateral facial pain evoked by innocuous cutaneous stimulation or manoeuvres. In classical and idiopathic TN, objective evidence of somatosensory system damage is often difficult to demonstrate. Neuroimaging studies suggest cortical structural alterations, though findings have been inconsistent, likely reflecting variability in case definitions and cortical measurement methodologies. We therefore investigated cortical thickness changes in a biologically homogeneous cohort of patients with right-sided TN using a whole-brain surface-based morphometry (SBM) approach. Methods: 60 patients with classical or idiopathic right-sided TN and 30 age- and sex-matched healthy controls underwent 3 T structural MRI. Cortical thickness was computed using FreeSurfer. Whole-brain vertex-wise group comparisons were performed using a General Linear Model (GLM) with a non-parametric permutation-based cluster-wise correction for multiple comparisons. Results: Compared with controls, patients with TN showed significantly reduced cortical thickness in eight clusters. The largest and most significant cluster was located in the left postcentral gyrus. Additional clusters were identified in the bilateral insular-temporal regions, the right precentral-postcentral region, the right lateral occipital cortex, and the right parieto-occipital junction. Cortical thickness within significant clusters did not correlate with disease duration. Conclusion: Right-sided TN is associated with focal cortical thinning involving both somatosensory and associative cortical regions. While involvement of insular, parietal, and occipital cortices is consistent with network-level structural reorganization observed in chronic pain conditions, thinning of the contralateral postcentral cortex may reflect central changes secondary to damage of primary trigeminal afferents.

  • Clinical Reasoning: A Patient With Progressive Sensory Neuropathy

    by Giuseppe Di Pietro, Pietro Falco, Eleonora Galosi, Enrico Evangelisti, Daniel Litewczuk, Gianfranco De Stefano, Giulia Di Stefano, Filippo Camerota, Caterina Leone, Andrea Truini

    A 74-year-old man presented with a 5-year history of progressive feet numbness followed by gait unsteadiness. Neurologic examination revealed absent tendon reflexes, markedly reduced vibration sens...

  • Open Access

    No Detectable Hippocampal Subfield Volume Differences in Medication-Free Episodic Cluster Headache During Active Bouts: A 3 T MRI Cross-Sectional Study

    by Davide Chiffi, Antonio Di Renzo, Gianfranco De Stefano, Daniel Litewczuk, Cherubino Di Lorenzo, Alessandro De Maio, Alessio Colangelo, Daniele Carpentieri, Marco Fiorelli, Marta Altieri, et al.

    Background: Cluster headache is a severe primary headache disorder in which neuroimaging studies have suggested involvement of hypothalamic, limbic, and pain-related networks. Although hippocampal abnormalities have been reported in some studies, volumetric findings remain inconsistent and may depend on disease state, treatment exposure, chronicity, and imaging methodology. We explored whole hippocampus and hippocampal subfield volumes in medication-free patients with episodic cluster headache scanned interictally during an active bout. Methods: In this cross-sectional case–control study, 26 patients with episodic cluster headache (eCH) and 20 age- and sex-matched healthy controls underwent 3 T brain MRI. Patients were scanned during an active bout but outside acute headache attacks and had not received preventive treatment for at least three months before MRI acquisition. Automated hippocampus segmentation and subfield volumetry were performed using FreeSurfer 7.4.1, followed by visual quality control by two neuroradiologists. Group comparisons were adjusted for age, sex, and total intracranial volume. Multiple comparisons were addressed using Bonferroni correction for whole hippocampal volumes and false discovery rate (FDR) correction for subfield and clinical analyses. Results: No significant differences were detected between eCH patients and healthy controls in whole hippocampus or hippocampal subfield volumes after correction for multiple comparisons. Descriptive analyses showed numerically higher volumes in patients across several regions, but these effects were small to moderate and did not reach statistical significance. Exploratory analyses showed a nominal association between right fimbria volume and pain intensity; however, this association did not survive FDR correction. Conclusions: This study found no evidence of detectable hippocampal macrostructural differences in medication-free eCH patients scanned interictally during active bouts using 3 T MRI-based subfield volumetry. These null findings should not be interpreted as proof of preserved hippocampal structure, but rather as absence of measurable volumetric alterations within the limits of the present sample size, acquisition protocol, and analytical framework. Longitudinal and multimodal studies, including in-bout and out-of-bout assessments, higher-resolution imaging, and neuropsychological covariates, are needed to clarify whether hippocampal involvement in eCH is structural, microstructural, functional, or state-dependent.

  • Glucagon-like peptide-1 receptor agonist treatment is associated with lower frequency of diabetic peripheral neuropathy and neuropathic pain in type 2 diabetes

    by Pietro Falco, Alessandra Di Flaviani, Eleonora Galosi, Stefania Angotti, Gianfranco De Stefano, Giuseppe Di Pietro, Giulia Di Stefano, Luca D'ONofrio, Enrico Evangelisti, Caterina Leone, et al.

    In this cross-sectional study, we investigated the frequency of diabetic peripheral neuropathy (DPN) and DPN-related neuropathic pain (painful DPN) in 500 consecutively enrolled patients with type 2 diabetes mellitus receiving standard treatment (n = 208), sodium–glucose cotransporter-2 inhibitors (SGLT2i; n = 152), or glucagon-like peptide-1 receptor agonists (GLP-1 RAs; n = 140). DPN was assessed through neurological examination, nerve conduction study, and skin biopsy when indicated; painful DPN was diagnosed using the grading system for neuropathic pain. Neuropathy severity and pain intensity were quantified with the Toronto Clinical Neuropathy Score, Pain Numerical Rating Scale, and Neuropathic Pain Symptom Inventory. The overall frequency of DPN was 58.6%, and painful DPN occurred in 26.2% of patients. GLP-1 RA treatment was associated with a lower frequency of DPN (46.4% vs 60.6% in the standard treatment group) and painful DPN (10.1% vs 35.1% and 28.3% in the standard treatment and SGLT2i groups, respectively). After adjustment for clinical and metabolic covariates, GLP-1 RA treatment was independently associated with lower odds of DPN (odds ratio [OR] 0.60, 95% confidence interval [CI] 0.37-0.96) and painful DPN (OR 0.32, 95% CI 0.15-0.65). Neuropathy severity and pain intensity were also lower in patients receiving GLP-1 RAs. GLP-1 RA treatment was associated with a reduced frequency and severity of both DPN and painful DPN, independent of clinical and metabolic covariates. While these findings suggest potential neuroprotective and antinociceptive effects, longitudinal studies are needed to establish causality and clarify the underlying mechanisms.


  • Open Access

    Quantitative Sensory Testing Identifies Altered Thermal and Pain Processing in Trigeminal Neuralgia

    by Gianfranco De Stefano, Daniel Litewczuk, Eleonora Galosi, Giuseppe Di Pietro, Pietro Falco, Caterina Leone, Jibril Osman‐Farah, Deepti Bhargava, Francis O'NEill, Bernhard Frank, et al.

    Introduction: This cross‐sectional study aims to assess somatosensory function in patients with trigeminal neuralgia (TN) using quantitative sensory testing (QST) and QST‐based sensory phenotyping, and to investigate their relationship with clinical findings, including etiology (classical and idiopathic TN), type of pain (paroxysmal pain only and concomitant continuous pain), and response to pharmacological treatment. Methods: Sixty‐five patients with classical or idiopathic TN underwent QST. Sensory alterations were quantified using z ‐scores derived from normative data, and sensory profiles were identified using a validated algorithm. Clinical characteristics, presence of concomitant continuous pain, and response to first‐line sodium channel blockers were systematically recorded through a structured questionnaire. Results: QST showed bilateral thermal hypoesthesia and pain hyperesthesia in the whole patient population. Cold detection threshold (CDT) was significantly reduced on the affected side compared to the unaffected side in patients with Classical TN. Idiopathic TN was associated with bilaterally elevated wind‐up ratio. Patients with purely paroxysmal pain showed a bilateral gain of function in heat pain thresholds. Sensory phenotyping identified mechanical hyperalgesia (49%) and thermal hyperalgesia (35%) as predominant phenotypes. A sensory loss phenotype was significantly associated with poor response to sodium‐channel blockers. Discussion: TN is characterized by subtle and complex bilateral sensory alterations, potentially suggesting central modification of sensory processing. The finding of asymmetrical CDT reduction may indicate peripheral Aδ‐fiber dysfunction. Sensory profiling may identify subgroups with distinctive treatment responses, with sodium channel blockers being less effective in sensory loss phenotype.


  • Open Access

    Muscle Ultrasound in Inclusion Body Myositis: Integrating Qualitative and Quantitative Approaches With Clinical and MRI Findings

    by Giuseppe Di Pietro, Pietro Falco, Rocco Costanzo, Eleonora Galosi, Gianfranco De Stefano, Enrico Evangelisti, Antonio Lauletta, Caterina Leone, Daniel Litewczuk, Giulia Di Stefano, et al.

    Introduction/Aims: Inclusion body myositis (IBM) is an inflammatory myopathy with an insidious onset, often making diagnosis challenging. Although neuroimaging has recently been included in diagnostic criteria, the role of muscle ultrasound—despite being a rapid and cost‐effective tool—in IBM has been less extensively characterized. In this study, we aimed to explore whether qualitative and quantitative muscle ultrasound measures reflect the pattern of muscle involvement in IBM and are associated with magnetic resonance imaging (MRI) findings. Methods: Thirteen patients with histologically confirmed IBM underwent clinical evaluation, including the IBM Functional Rating Scale (IBM‐FRS) and Medical Research Council (MRC) grading. Qualitative (Heckmatt scale, from 1 to 4) and quantitative (muscle echo‐intensity and thickness z‐scores) ultrasound assessments were performed on fourteen muscles bilaterally. Lower limb muscle MRI was conducted using T1‐weighted (with Mercuri score) and STIR sequences. Correlations between ultrasound parameters and MRI findings were analyzed. Results: Qualitative ultrasound assessment showed increased echogenicity, mainly in flexor digitorum profundus, vastus lateralis, rectus femoris, tibialis anterior, and medial gastrocnemius. Quantitative analysis confirmed elevated echo‐intensity in these muscles, with milder involvement of tibialis anterior and lateral gastrocnemius. Both qualitative Heckmatt scores and quantitative muscle echo‐intensity scores showed positive associations with MRI T1 Mercuri scores ( p < 0.001). Discussion: In this study, both qualitative and quantitative muscle ultrasound reflected the characteristic pattern of muscle involvement in IBM and showed associations with MRI findings, supporting their utility in describing the pattern and extent of muscle damage.

  • Open Access

    Recognizing solitary pontine lesion–related trigeminal neuralgia as a distinct entity: The need for an updated ICHD classification

    by Giulia Di Stefano, Gianfranco De Stefano, Melanie H. Kristt, Raymond F. Sekula, Andrea Truini


  • Open Access

    Comparative Analysis of Small Nerve Fiber Density in Fibromyalgia Syndrome and Small Fiber Neuropathy

    by Pietro Falco, Eleonora Galosi, Caterina Maria Leone, Gianfranco De Stefano, Giuseppe Di Pietro, Giulia Di Stefano, Nicoletta Esposito, Enrico Evangelisti, Daniel Litewczuk, Cristina Mollica, et al.

    Background/Objectives: Fibromyalgia syndrome is commonly associated with reduced intraepidermal nerve fiber density (IENFD), as assessed by skin biopsy, a finding referred to as small fiber pathology (SFP-FMG). The clinical significance of this abnormality, and how it relates to symptoms in fibromyalgia, remains uncertain. Reduced IENFD also represents the defining feature of small fiber neuropathy (SFN). While previous observations suggest that IENFD reduction is generally less severe in SFP-FMG than in SFN, no study has directly confirmed this finding in a large cohort. This retrospective study aimed to compare the severity of IENFD reduction in patients with SFP-FMG and those with SFN. Methods: To account for age and sex differences, we used the age-and sex-adjusted axonal loss density (ALD), defined as the percentage reduction from normative IENFD values. We retrospectively analyzed skin biopsy data from 73 patients with SFP-FMG and 134 patients diagnosed with SFN. Results: We found that the reduction in IENFD was significantly milder in patients with SFP-FMG than in those with SFN both at distal and proximal sites. Receiver operating characteristic analysis indicated that an ALD threshold of 37.6% provided good specificity for distinguishing SFN from SFP-FMG. Conclusions: These findings indicate that small fiber damage in fibromyalgia syndrome is quantitatively mild compared to patients with SFN. This may explain the absence of detectable sensory deficits on clinical examination and suggests a limited contribution of peripheral nerve damage to the pathophysiology of fibromyalgia syndrome.


  • Open Access

    Trigeminal neuropathy presenting secondary to SARS-CoV-2 infection

    by Francis O'NEill, Gianfranco De Stefano, Mike Pridgeon, Deepti Bhargava, Andrew Marshall, Bernhard Frank

    Introduction: A 58-year-old woman presented to a multidisciplinary facial pain clinic in October 2021 complaining of a constant pain in the right side of her face since contracting coronavirus SARS-CoV-2 18 months earlier. The pain extending from the right temple down to her right cheek extraorally and including the maxillary teeth and right side of tongue intraorally. This was accompanied by anosmia, diplopia on lateral gaze, and dizziness. Methods: Clinical examination was supplemented with several neurophysiological tests to confirm the diagnosis including an MRI brain scan, quantitative sensory testing, electrophysiological blink reflex testing, corneal confocal microscopy, and pain and short-form anxiety and depression questionnaires. Results: Quantitative sensory testing showed unilateral loss of perception in thermal and mechanical sensibility and bilateral hyperalgesia indicating central sensitization. Bilateral corneal confocal microscopy showed an abnormally reduced corneal nerve fibre length on the right side. MRI, blink reflex, and masseter inhibitory testing findings were normal. Conclusion: This case study is the first case of trigeminal neuropathy related to SARS-CoV-2 infection reported in the literature. It also discusses the successful management of the patient's trigeminal neuropathic pain.